Tiedemann Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tiedemann Advisors, LLC

$2.31 Billion
Q3 2023

A detailed history of Tiedemann Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 380 shares of REGN stock, worth $270,712. This represents 0.01% of its overall portfolio holdings.

Number of Shares

380

Previous 380 -0.0%

Holding current value

$270,712

Previous $273,000 14.29%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $2,800 - $3,321	-4 Reduced 1.04%	380 $273,000
Q1 2023 Apr 26, 2023	SELL	$680.49 - $826.97 $3,402 - $4,134	-5 Reduced 1.29%	384 $315,000
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $6,353 - $6,897	9 Added 2.37%	389 $280,000
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $4,386 - $5,910	-8 Reduced 2.06%	380 $225,000
Q1 2022 Apr 27, 2022	BUY	$595.12 - $698.43 $4,760 - $5,587	8 Added 2.11%	388 $271,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $11,480 - $13,619	-20 Reduced 5.0%	380 $230,000
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $12,765 - $15,080	-27 Reduced 6.32%	400 $224,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $5,807 - $7,126	13 Added 3.14%	427 $201,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $188,450 - $239,544	-394 Reduced 48.76%	414 $200,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $18,521 - $22,379	-34 Reduced 4.04%	808 $453,000
Q2 2020 Nov 12, 2020	BUY	$493.32 - $643.92 $214,100 - $279,461	434 Added 106.37%	842 $524,000
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $241,726 - $315,520	-490 Reduced 54.57%	408 $254,000
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $34,626 - $50,926	103 Added 12.96%	898 $438,000
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $6,030 - $8,283	-22 Reduced 2.69%	795 $299,000
Q3 2019 Nov 06, 2019	BUY	$273.46 - $318.39 $33,362 - $38,843	122 Added 17.55%	817 $226,000
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $142,609 - $197,454	-476 Reduced 40.65%	695 $218,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $50,230 - $59,341	135 Added 13.03%	1,171 $480,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $108,469 - $130,181	323 Added 45.3%	1,036 $387,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $6,320 - $7,353	18 Added 2.59%	713 $288,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $13,091 - $15,869	46 Added 7.09%	695 $240,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $279,965 - $327,096	649	649 $286,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.

Account

Tiedemann Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History